BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37757490)

  • 21. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
    Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
    Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety and Efficacy of Ferric Carboxymaltose in the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease, in Routine Daily Practice.
    Stein J; Aksan A; Klemm W; Nip K; Weber-Mangal S; Dignass A
    J Crohns Colitis; 2018 Jun; 12(7):826-834. PubMed ID: 29955835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Hepcidin and Soluble Transferrin Receptor in the Assessment of Iron Metabolism in Children on a Vegetarian Diet.
    Ambroszkiewicz J; Klemarczyk W; Mazur J; Gajewska J; Rowicka G; Strucińska M; Chełchowska M
    Biol Trace Elem Res; 2017 Dec; 180(2):182-190. PubMed ID: 28342014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose.
    Drakou A; Margeli A; Theodorakopoulou S; Agrogiannis I; Poziopoulos C; Papassotiriou I; Vlahakos DV
    Blood Cells Mol Dis; 2016 Jul; 59():100-5. PubMed ID: 27282576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is cord blood hepcidin influenced by the low-grade acute-phase response occurring during delivery? A small-scale longitudinal study.
    Hoppe M; Hulthén L; Samuelson G
    J Matern Fetal Neonatal Med; 2019 Jul; 32(13):2166-2172. PubMed ID: 29325459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Hepcidin Concentrations Decline during Pregnancy and May Identify Iron Deficiency: Analysis of a Longitudinal Pregnancy Cohort in The Gambia.
    Bah A; Pasricha SR; Jallow MW; Sise EA; Wegmuller R; Armitage AE; Drakesmith H; Moore SE; Prentice AM
    J Nutr; 2017 Jun; 147(6):1131-1137. PubMed ID: 28424258
    [No Abstract]   [Full Text] [Related]  

  • 27. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA; Keating GM
    Drugs; 2009; 69(6):739-56. PubMed ID: 19405553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron status in patients with chronic heart failure.
    Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P
    Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aetiology of anaemia during pregnancy: a study to evaluate the contribution of iron deficiency and common infections in pregnant Ugandan women.
    Baingana RK; Enyaru JK; Tjalsma H; Swinkels DW; Davidsson L
    Public Health Nutr; 2015 Jun; 18(8):1423-35. PubMed ID: 25222882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible role for hepcidin in the detection of iron deficiency in severely anaemic HIV-infected patients in Malawi.
    Huibers MHW; Calis JC; Allain TJ; Coupland SE; Phiri C; Phiri KS; Swinkels DW; Boele van Hensbroek M; Bates I
    PLoS One; 2020; 15(2):e0218694. PubMed ID: 32107492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depleted iron stores and iron deficiency anemia associated with reduced ferritin and hepcidin and elevated soluble transferrin receptors in a multiethnic group of preschool-age children.
    Weiler HA; Jean-Philippe S; Cohen TR; Vanstone CA; Agellon S
    Appl Physiol Nutr Metab; 2015 Sep; 40(9):887-94. PubMed ID: 26288393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of hemoglobin, serum ferritin, and serum transferrin receptor during iron supplementation in pregnancy: a prospective study.
    Madhavan Nair K; Bhaskaram P; Balakrishna N; Ravinder P; Sesikeran B
    Nutrition; 2004 Oct; 20(10):896-9. PubMed ID: 15474878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of a low monthly dose of intravenous iron sucrose in peritoneal dialysis patients.
    Mitsopoulos E; Lysitska A; Pateinakis P; Lamprou V; Intzevidou E; Minasidis I; Katsaounou C; Kougioumtzidou O; Anagnostou N; Lemonidis N; Papadopoulou D
    Int Urol Nephrol; 2020 Feb; 52(2):387-392. PubMed ID: 31894555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of soluble transferrin receptor and hepcidin in the assessment of iron status in children with cystic fibrosis.
    Uijterschout L; Swinkels DW; Akkermans MD; Zandstra T; Nuijsink M; Hendriks D; Hudig C; Tjalsma H; Vos R; van Goudoever JB; Brus F
    J Cyst Fibros; 2014 Dec; 13(6):639-44. PubMed ID: 24735882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron deficiency and anemia are prevalent in women with multiple gestations.
    Ru Y; Pressman EK; Cooper EM; Guillet R; Katzman PJ; Kent TR; Bacak SJ; O'Brien KO
    Am J Clin Nutr; 2016 Oct; 104(4):1052-1060. PubMed ID: 27581469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.
    Macdougall IC; White C; Anker SD; Bhandari S; Farrington K; Kalra PA; McMurray JJV; Murray H; Steenkamp R; Tomson CRV; Wheeler DC; Winearls CG; Ford I;
    Am J Nephrol; 2018; 48(4):260-268. PubMed ID: 30304714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
    Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
    Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulation of iron metabolism modulators in virologically suppressed HIV-infected patients.
    Garrido-Rodríguez V; Álvarez-Ríos AI; Olivas-Martínez I; Pozo-Balado MDM; Bulnes-Ramos Á; Leal M; Pacheco YM
    Front Immunol; 2022; 13():977316. PubMed ID: 36505484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for iron deficiency anemia in obstetric and gynecologic patients: A systematic review and meta-analysis.
    Shin HW; Go DY; Lee SW; Choi YJ; Ko EJ; You HS; Jang YK
    Medicine (Baltimore); 2021 May; 100(20):e24571. PubMed ID: 34011020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.